[Letrozole versus gonadotropin-releasing hormone antagonist during luteal phase in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial].

Cheng, Z X; Kong, G; Zhang, C L; Zhao, Y N

Cheng, Z X; Kong, G; Zhang, C L; Zhao, Y N.

Affiliation

Cheng ZX; Center for Reproductive Medicine, Shenyang Women and Children's Hospital, Shenyang 110004, China.

Zhonghua Fu Chan Ke Za Zhi ; 55(1): 9-14, 2020 Jan 25.

Article in Zh | MEDLINE | ID: mdl-32074767

Subject(s)

Gonadotropin-Releasing Hormone/antagonists & inhibitors; Infertility, Female/therapy; Letrozole/therapeutic use; Ovarian Hyperstimulation Syndrome/prevention & control; Ovulation Induction; Estradiol/blood; Female; Fertilization in Vitro; Humans; Luteal Phase; Luteinizing Hormone/blood; Progesterone/blood

Key words

Gonadotropin- releasing hormone; Letrozole; Luteal phase; Ovarian hyperstimulation syndrome; Randomized controlled trial

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovulation Induction / Gonadotropin-Releasing Hormone / Ovarian Hyperstimulation Syndrome / Letrozole / Infertility, Female Type of study: Clinical_trials Limits: Female / Humans Language: Zh Journal: Zhonghua Fu Chan Ke Za Zhi Year: 2020 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google